Division of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA.
Sanford Consortium for Regenerative Medicine, La Jolla, CA; and.
Blood. 2020 Sep 17;136(12):1394-1401. doi: 10.1182/blood.2019004158.
Vitamin C serves as a cofactor for Fe(II) and 2-oxoglutarate-dependent dioxygenases including TET family enzymes, which catalyze the oxidation of 5-methylcytosine into 5-hydroxymethylcytosine and further oxidize methylcytosines. Loss-of-function mutations in epigenetic regulators such as TET genes are prevalent in hematopoietic malignancies. Vitamin C deficiency is frequently observed in cancer patients. In this review, we discuss the role of vitamin C and TET proteins in cancer, with a focus on hematopoietic malignancies, T regulatory cells, and other immune system cells.
维生素 C 作为辅因子,参与依赖 Fe(II)和 2-氧代戊二酸的双加氧酶,包括 TET 家族酶,这些酶可催化 5-甲基胞嘧啶氧化为 5-羟甲基胞嘧啶,并进一步氧化甲基胞嘧啶。表观遗传调节剂(如 TET 基因)的功能丧失突变在血液恶性肿瘤中很常见。癌症患者经常缺乏维生素 C。在这篇综述中,我们讨论了维生素 C 和 TET 蛋白在癌症中的作用,重点是血液恶性肿瘤、T 调节细胞和其他免疫系统细胞。